Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-097773
Filing Date
2024-11-14
Accepted
2024-11-14 06:30:28
Documents
4
Period of Report
2024-11-14

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0221218-6k_immuron.htm 6-K 14020
2 NOTIFICATION OF CESSATION OF SECURITIES - IMC ea022121801ex99-1_immuron.htm EX-99.1 22882
3 CHANGE OF DIRECTOR'S INTEREST NOTICE (DP RS) ea022121801ex99-2_immuron.htm EX-99.2 86973
4 GRAPHIC ex99-1_001.jpg GRAPHIC 1140
  Complete submission text file 0001213900-24-097773.txt   126647
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 241456973
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)